| 产品详情 |
| Edit |   |
| Product Name | Recombinant Cynomolgus Siglec-2/CD22 Fc Chimera Protein, CF |
| Description | Purity >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining. MW (observed): 115-134 kDa, reducing conditions. MW (theoretical): 102 kDa. The Recombinant Cynomolgus Siglec-2/CD22 Fc Chimera Protein from R&D Systems is derived from HEK293. The Recombinant Cynomolgus Siglec-2/CD22 Fc Chimera Protein has been validated for the following applications: Bioactivity. |
| Size | 50 ug |
| Concentration | n/a |
| Applications | Bioactivity |
| Other Names | B-cell receptor CD22, BL-CAM, B-lymphocyte cell adhesion molecule, CD22, CD22 antigenMGC130020, CD22 molecule, sialic acid binding Ig-like lectin 2, Sialic acid-binding Ig-like lectin 2, Siglec2, SIGLEC-2, SIGLEC2FLJ22814, T-cell surface antigen Leu-14 |
| Gene, Accession, CAS # | Gene ID: 102130968, Accession: EHH59463 |
| Catalog # | 10031-SL-050 |
| Price | |
| Order / More Info | Recombinant Cynomolgus Siglec-2/CD22 Fc Chimera Protein, CF from R&D SYSTEMS, INC. |
| Product Specific References | n/a |
| 产品资料 |
|
|